Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 24, 1999
CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasmsO Sezer, D Jugovic, J U Blohmer, et al.
Anticancer Research|May 1, 2001
A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancerD Lüfter, A Richter, S Günther, et al.
Deutsche Medizinische Wochenschrift (1946)|May 26, 1999
[Hypoxia in solid tumors]T Beinert, H G Mergenthaler, O Sezer, et al.
Breast Cancer Research and Treatment|January 9, 2009
Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing modelMichael Patrick Lux, M Hartmann, C Jackisch, et al.
Annals of Hematology|November 7, 1999
Eosinophilia during fludarabine treatment of chronic lymphocytic leukemiaO Sezer, P Schmid, M Hallek, et al.
Anticancer Research|June 25, 2003
Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancerD Lüftner, S Mazurek, P Henschke, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancerN Bruhn, T Beinert, C Oehm, et al.
Breast Cancer Research and Treatment|August 21, 2002
Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cellsE Elstner, E A Williamson, C Zang, et al.
Breast Cancer Research and Treatment|January 7, 2011
High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?A C Regierer, R Wolters, C Kurzeder, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations?R Wolters, A C Regierer, L Schwentner, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 24, 1999
CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasmsO Sezer, D Jugovic, J U Blohmer, et al.
Anticancer Research|May 1, 2001
A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancerD Lüfter, A Richter, S Günther, et al.
Deutsche Medizinische Wochenschrift (1946)|May 26, 1999
[Hypoxia in solid tumors]T Beinert, H G Mergenthaler, O Sezer, et al.
Breast Cancer Research and Treatment|January 9, 2009
Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing modelMichael Patrick Lux, M Hartmann, C Jackisch, et al.
Annals of Hematology|November 7, 1999
Eosinophilia during fludarabine treatment of chronic lymphocytic leukemiaO Sezer, P Schmid, M Hallek, et al.
Anticancer Research|June 25, 2003
Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancerD Lüftner, S Mazurek, P Henschke, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancerN Bruhn, T Beinert, C Oehm, et al.
Breast Cancer Research and Treatment|August 21, 2002
Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cellsE Elstner, E A Williamson, C Zang, et al.
Breast Cancer Research and Treatment|January 7, 2011
High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?A C Regierer, R Wolters, C Kurzeder, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations?R Wolters, A C Regierer, L Schwentner, et al.
Pageof 17